IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v16y2025i1d10.1038_s41467-025-56894-8.html
   My bibliography  Save this article

Targeting ELOVL6 to disrupt c-MYC driven lipid metabolism in pancreatic cancer enhances chemosensitivity

Author

Listed:
  • Ana García García

    (Pozuelo de Alarcón)

  • María Ferrer Aporta

    (Pozuelo de Alarcón)

  • Germán Vallejo Palma

    (Avenida de Cordoba s/n)

  • Antonio Giráldez Trujillo

    (Avenida de Cordoba s/n)

  • Raquel Castillo-González

    (Avenida de Cordoba s/n
    Universidad Autónoma de Madrid (UAM))

  • David Calzón Lozano

    (Pozuelo de Alarcón)

  • Alberto Mora Perdiguero

    (Pozuelo de Alarcón)

  • Raúl Muñoz Velasco

    (Pozuelo de Alarcón)

  • Miguel Colina Castro

    (Pozuelo de Alarcón)

  • Elena Simone Benito

    (Pozuelo de Alarcón)

  • Raúl Torres-Ruiz

    (Centro Nacional de Investigaciones Oncológicas (CNIO)
    Medioambientales y Tecnológicas (CIEMAT)
    Instituto de Investigación Sanitaria Fundación Jiménez Díaz
    Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER))

  • Sandra Rodriguez-Perales

    (Centro Nacional de Investigaciones Oncológicas (CNIO))

  • Jonas Dehairs

    (KU Leuven)

  • Johannes V. Swinnen

    (KU Leuven)

  • Juan Carlos Garcia-Cañaveras

    (106)

  • Agustín Lahoz

    (106)

  • Sandra Montalvo Quirós

    (Pozuelo de Alarcón)

  • Carlos Pozo-Rojas

    (Pozuelo de Alarcón)

  • Clara Luque Rioja

    (Complutense University of Madrid
    Avenida de Cordoba s/n)

  • Francisco Monroy

    (Complutense University of Madrid
    Avenida de Cordoba s/n)

  • Diego Herráez-Aguilar

    (Pozuelo de Alarcón)

  • Marina Alonso Riaño

    (Avenida de Cordoba s/n)

  • José Luis Rodríguez Peralto

    (Avenida de Cordoba s/n)

  • Víctor Javier Sánchez-Arévalo Lobo

    (Pozuelo de Alarcón
    Avenida de Cordoba s/n)

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer with a 12% survival rate, highlighting the need for novel therapies. c-MYC overexpression, driven by upstream mutations and amplifications, reprograms tumor metabolism and promotes proliferation, migration and metastasis. This study identifies ELOVL6, a fatty acid elongase regulated by c-MYC, as a potential therapeutic target. Using PDAC mouse models and cell lines, we show that c-MYC directly upregulates ELOVL6 during tumor progression. Genetic or chemical inhibition of ELOVL6 reduces proliferation and migration by altering fatty acid composition, affecting membrane rigidity, permeability and pinocytosis. These changes increase Abraxane uptake and show a synergistic effect when combined with ELOVL6 inhibition in vitro. In vivo, ELOVL6 interference significantly suppresses tumor growth and improves Abraxane response, prolonging survival. These findings position ELOVL6 as a promising target for improving PDAC treatment outcomes.

Suggested Citation

  • Ana García García & María Ferrer Aporta & Germán Vallejo Palma & Antonio Giráldez Trujillo & Raquel Castillo-González & David Calzón Lozano & Alberto Mora Perdiguero & Raúl Muñoz Velasco & Miguel Coli, 2025. "Targeting ELOVL6 to disrupt c-MYC driven lipid metabolism in pancreatic cancer enhances chemosensitivity," Nature Communications, Nature, vol. 16(1), pages 1-23, December.
    • Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-56894-8
    DOI: 10.1038/s41467-025-56894-8
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-025-56894-8
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-025-56894-8?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Susanne Walz & Francesca Lorenzin & Jennifer Morton & Katrin E. Wiese & Björn von Eyss & Steffi Herold & Lukas Rycak & Hélène Dumay-Odelot & Saadia Karim & Marek Bartkuhn & Frederik Roels & Torsten Wü, 2014. "Correction: Corrigendum: Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles," Nature, Nature, vol. 516(7531), pages 440-440, December.
    2. Jacopo Frallicciardi & Josef Melcr & Pareskevi Siginou & Siewert J. Marrink & Bert Poolman, 2022. "Membrane thickness, lipid phase and sterol type are determining factors in the permeability of membranes to small solutes," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    3. Yehuda Schlesinger & Oshri Yosefov-Levi & Dror Kolodkin-Gal & Roy Zvi Granit & Luriano Peters & Rachel Kalifa & Lei Xia & Abdelmajeed Nasereddin & Idit Shiff & Osher Amran & Yuval Nevo & Sharona Elgav, 2020. "Single-cell transcriptomes of pancreatic preinvasive lesions and cancer reveal acinar metaplastic cells’ heterogeneity," Nature Communications, Nature, vol. 11(1), pages 1-18, December.
    4. Marteinn Thor Snaebjornsson & Almut Schulze, 2019. "Tumours use a metabolic twist to make lipids," Nature, Nature, vol. 566(7744), pages 333-334, February.
    5. Susanne Walz & Francesca Lorenzin & Jennifer Morton & Katrin E. Wiese & Björn von Eyss & Steffi Herold & Lukas Rycak & Hélène Dumay-Odelot & Saadia Karim & Marek Bartkuhn & Frederik Roels & Torsten Wü, 2014. "Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles," Nature, Nature, vol. 511(7510), pages 483-487, July.
    6. M. Martinez-Lage & R. Torres-Ruiz & P. Puig-Serra & P. Moreno-Gaona & M. C. Martin & F. J. Moya & O. Quintana-Bustamante & S. Garcia-Silva & A. M. Carcaboso & P. Petazzi & C. Bueno & J. Mora & H. Pein, 2020. "In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells," Nature Communications, Nature, vol. 11(1), pages 1-14, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Nicole M. Sodir & Luca Pellegrinet & Roderik M. Kortlever & Tania Campos & Yong-Won Kwon & Shinseog Kim & Daniel Garcia & Alessandra Perfetto & Panayiotis Anastasiou & Lamorna Brown Swigart & Mark J. , 2022. "Reversible Myc hypomorphism identifies a key Myc-dependency in early cancer evolution," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    2. Joy Edwards-Hicks & Huizhong Su & Maurizio Mangolini & Kubra K. Yoneten & Jimi Wills & Giovanny Rodriguez-Blanco & Christine Young & Kevin Cho & Heather Barker & Morwenna Muir & Ania Naila Guerrieri &, 2022. "MYC sensitises cells to apoptosis by driving energetic demand," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    3. Matthias Pöhnl & Marius F. W. Trollmann & Rainer A. Böckmann, 2023. "Nonuniversal impact of cholesterol on membranes mobility, curvature sensing and elasticity," Nature Communications, Nature, vol. 14(1), pages 1-12, December.
    4. Anne M. Kiirikki & Hanne S. Antila & Lara S. Bort & Pavel Buslaev & Fernando Favela-Rosales & Tiago Mendes Ferreira & Patrick F. J. Fuchs & Rebeca Garcia-Fandino & Ivan Gushchin & Batuhan Kav & Norber, 2024. "Overlay databank unlocks data-driven analyses of biomolecules for all," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    5. Lee Shaashua & Aviad Ben-Shmuel & Meirav Pevsner-Fischer & Gil Friedman & Oshrat Levi-Galibov & Subhiksha Nandakumar & Debra Barki & Reinat Nevo & Lauren E. Brown & Wenhan Zhang & Yaniv Stein & Chen L, 2022. "BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling," Nature Communications, Nature, vol. 13(1), pages 1-21, December.
    6. Yi Xu & Michael H. Nipper & Angel A. Dominguez & Zhenqing Ye & Naoki Akanuma & Kevin Lopez & Janice J. Deng & Destiny Arenas & Ava Sanchez & Francis E. Sharkey & Colin M. Court & Aatur D. Singhi & Hua, 2024. "Reconstitution of human PDAC using primary cells reveals oncogenic transcriptomic features at tumor onset," Nature Communications, Nature, vol. 15(1), pages 1-16, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-56894-8. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.